SCHEMBL6006269

SCHEMBL6006269

C=CCN(CC=C)P(=O)(O)O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.33
LPAR2 Q9HBW0 1/20 0.31
LPAR3 Q9UBY5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9580132 0.82 ALDH1A1 (0.38) ALDH1A1LMNA
SCHEMBL8850070 0.82 ALDH1A1 (0.31) ALDH1A1
SCHEMBL10786844 0.79 ALDH1A1 (0.38) ALDH1A1
SCHEMBL4342798 0.78 ALDH1A1 (0.41) ALDH1A1LPAR2LPAR3
SCHEMBL423317 0.77 ALDH1A1 (0.39) ALDH1A1
Phosphoric Acid SCHEMBL29092860 0.74 ALDH1A1 (0.42) ALDH1A1LPAR2LPAR3
SCHEMBL3433861 0.74
SCHEMBL19348651 0.74 LPAR2 (0.38) LPAR2LPAR3
SCHEMBL11883295 0.74
SCHEMBL4212873 0.72 ALDH1A1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430002-B1 PROCESS FOR THE PREPARATION OF A COMPOUND USEFUL AS AN INHIBITOR OF TAFIA SANOFI SA (FR) 2013-07-24 EP claimed
EP-1110992-B1 Solid polymer electrolyte having high-durability TOYOTA CHUO KENKYUSHO KK (JP) 2006-08-02 EP claimed
US-6607856-B2 Solid polymer electrolyte having high-durability KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2003-08-19 US claimed
US-20010038937-A1 Solid polymer electrolyte having high-durability KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2001-11-08 US claimed
EP-1110992-A1 Solid polymer electrolyte having high-durability Kabushiki Kaisha Toyota Chuo Kenkyusho (JP) 2001-06-27 EP claimed
WO-2025031091-A1 PROCESS FOR TREATING A METAL SUBSTRATE AND TREATED METAL OBTAINED BY THE SAME SPECIALTY OPERATIONS FRANCE (FR) 2025-02-13 WO disclosed
CN-112384517-B Heteroaryl compounds and uses thereof 新旭生技股份有限公司 2023-07-14 CN disclosed
EP-3222624-B1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS CO LTD (JP) 2019-11-06 EP disclosed
US-10287165-B2 Imidic acid compound having divalent anion and process for producing the same CENTRAL GLASS CO., LTD. (JP) 2019-05-14 US disclosed
EP-3222624-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME Central Glass Co., Ltd. (JP) 2017-09-27 EP disclosed
US-20170267528-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS CO., LTD. (JP) 2017-09-21 US disclosed
EP-1110992-B1 Solid polymer electrolyte having high-durability TOYOTA CHUO KENKYUSHO KK (JP) 2006-08-02 EP disclosed
US-20010038937-A1 Solid polymer electrolyte having high-durability KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2001-11-08 US disclosed
EP-1110992-A1 Solid polymer electrolyte having high-durability Kabushiki Kaisha Toyota Chuo Kenkyusho (JP) 2001-06-27 EP disclosed
EP-1110992-A1 Solid polymer electrolyte having high-durability Kabushiki Kaisha Toyota Chuo Kenkyusho (JP) 2001-06-27 EP disclosed
EP-0563730-A2 Alkenylaminoalkylene phosphonic acid esters and process for the preparation of copolymers comprising alkenylaminoalkylene phosphonates and ethylenic unsaturated compounds HOECHST AKTIENGESELLSCHAFT (DE) 1993-10-06 EP disclosed
EP-0495355-A1 Copolymers of diallylaminoalkylene phosphonates and unsaturated carboxylic acids HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-22 EP disclosed
US-4178398-A Amidophosphate reaction products used as flameproofing agents CIBA-GEIGY CORPORATION (US) 1979-12-11 US disclosed
US-4094929-A FLAMEPROOFING CIBA-GEIGY CORPORATION (US) 1978-06-13 US disclosed
US-4059532-A CELLULOSE CIBA-GEIGY CORPORATION (US) 1977-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267528-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CA2, CA6, CHRM1 ALDH1A1 975/4885LMNA 4080/4885LPAR2 2436/4885
US-10287165-B2 Imidic acid compound having divalent anion and process for producing the same CA2, CA6, CHRM1 ALDH1A1 975/4885LMNA 4080/4885LPAR2 2436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.